-
1تقرير
المصدر: A Phase II Trial Of The Epothilone B Analog BMS-247550 (NSC 710428D) In Patients With Hepatobiliary Cancer
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00023946Test
-
2تقريرVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
المصدر: Phase I Study of a Recombinant Fowl Pox Vaccine rF-CEA (6D)/TRICOM Alone or With GM-CSF in Patients With Advanced CEA Expressing Adenocarinomas
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00028496Test
-
3تقرير
المصدر: A Phase II Trial of OSI-774 in Patients With Hepatocellular or Biliary Carcinoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00033462Test
-
4تقرير
المصدر: A Phase II Study of GW572016 (Lapatanib) in Locally Advanced or Metastatic Hepato-Biliary Cancers
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00101036Test
-
5تقرير
المصدر: Peck J, WeL, ZalupskM, O'Ne B, Vlalona Calero M, Beka-Saab T. HER2/neu may not be an terestg target bry cancers: results of an early phase study wh lapat. Oncology. 2012;82(3):175-9. do 10.1159/000336488. Epub 2012 Mar 15.
Bekaii-Saab T, Markowitz J, Prescott N, Sadee W, Heerema N, Wei L, Dai Z, Papp A, Campbell A, Culler K, Balint C, O'Neil B, Lee RM, Zalupski M, Dancey J, Chen H, Grever M, Eng C, Villalona-Calero M. A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas. Clin Cancer Res. 2009 Sep 15;15(18):5895-901. doi: 10.1158/1078-0432.CCR-09-0465. Epub 2009 Sep 8.
A Phase II Study of Efficacy and Tolerability of GW572016 in Patients With Advanced Hepatocellular and Biliary Carcinomasالوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00107536Test
